Age of AI Europe, 2026
March 10, 2026 · London
Learn more >
Robin Jones
Product Owner for AI and Gen AI
AstraZeneca
Robin has dedicated over a decade to transforming how healthcare professionals engage with emerging technologies. As a leader in generative AI integration, Robin has spearheaded AstraZeneca's UK initiatives, focusing on tools like ChatGPT to enhance clinical and commercial strategies. Since 2023, Robin has been instrumental in developing applications of Large Language Models in health technology assessments and marketing, ensuring compliance with industry standards. Robin’s current work includes designing workshops to demonstrate AI's potential in campaign planning and decision-making, blending technical expertise with practical business insights.
Sessions
Duncan Arbour
1:20 PM – 1:50 PM
After the AI Hype: Rebuilding the Pharma Client–Agency Operating Model
- What’s breaking and what’s worth protecting: why “hours + assets” is collapsing under in-house AI, consolidation and procurement logic, and how to avoid the race-to-the-bottom trap.
- Inside the client firewall: how secure LLMs/copilots are already reshaping asset ownership, accountability and risk and where agencies still earn their keep as a governance + quality creators.
- Hear where value is moving next: from making stuff to designing the system, hear how clear swimlanes, shared guardrails, and an outcomes-first collaboration model can lead to improved HCP/patient impact - not just increased throughput.
Outcome: Leave with a practical proposal for redrawn client-agency swimlanes, with a clear view on what to strip out and what to protect.
Duncan Arbour, Head of AI Innovation, Kinetic, Syneos Health
Robin Jones, Product Owner for AI and Gen AI, AstraZeneca